We have identified a secreted glycoprotein, neural epidermal growth factor-like like 2 (NELL2), in a screen designed to isolate molecules regulating sensory neuron genesis and differentiation in the dorsal root ganglia (DRG). In investigating NELL2 expression during embryogenesis, we demonstrate here that NELL2 is highly regulated spatially and temporally, being only transiently expressed in discrete regions of the central (CNS) and peripheral nervous systems (PNS) and in a subset of mesoderm derived structures during their peak periods of development. In the CNS and PNS, NELL2 is maximally expressed as motor and sensory neurons differentiate. Interestingly, its expression is restricted to sublineages of the neural crest, being strongly expressed throughout the immature DRG, but excluded from sympathetic ganglia. Similarly during muscle development, NELL2 is specifically expressed by hypaxial muscle precursor cells in the differentiating somite and derivatives in the forelimbs and body wall, but not by epaxial muscle precursors. Furthermore, NELL2 is differentially regulated in the CNS and PNS; in the CNS, NELL2 is only expressed by nascent, post-mitotic neurons as they commence their differentiation, yet in the PNS, NELL2 is expressed by subsets of progenitor cells in addition to nascent neurons. Based on this restricted spatial and temporal expression pattern, functional studies are in progress to determine NELL2's role during neuronal differentiation in both the PNS and CNS. q
Results and discussion
The restricted expression of subsets of genes to a particular tissue during specific developmental stages ultimately results in the differentiation of discrete cell types. The goal is to identify key genes that regulate the genesis and differentiation of these discrete cell types. The dorsal root ganglion (DRG) is an experimentally rich system in which this question pertaining to vertebrate neurogenesis can be investigated. DRG derives from a subpopulation of migrating neural crest cells that coalesce laterally to the neural tube (Lallier and Bronner-Fraser, 1988) . As the DRG matures, discrete cell types emerge from a pool of differentiating progenitor cells. Mature DRG contains approximately 20 types of post-mitotic neurons that differ in their sensory modalities, morphologies, and biochemistry, in addition to support glial cells (Scott, 1992) .
Once DRG have formed, sensory neurons mature and innervate discrete central and peripheral targets, followed by an extensive period of target-regulated programmed cell death (Lindsay, 1996) . However, the intervening cellular and molecular events that occur prior to the period of target-mediated cell death, yet subsequent to neural crest migration, remain incompletely characterized. An elucidation of these events is required because it is during this time period when the majority of neurogenesis and differentiation of discrete classes of sensory neurons occurs. Certainly, molecules such as the neurotrophins and their cognate Trk receptors, the transcription factors neurogenin 1 and 2 and members of the ETS family, and Notch and Delta-1 interactions play critical roles during sensory neurogenesis (Lindsay, 1996; Lin et al., 1998; Ma et al., 1999; Arber et al., 2000; Wakamatsu et al., 2000; Morrison et al., 2000) . However, given the complexity of cellular and molecular interactions mediating DRG development, it is evident that additional molecular mechanisms must be elucidated. Ultimately an interplay between extrinsic and intrinsic signals is thought to sculpt the formation of the final pattern of cell types within the DRG (Morrison, 2001; Sommer, 2001) . Neurogenesis in the nascent chick DRG peaks at HH st 25/E4.5-5, which is followed by target innervation and programmed cell death of post-mitotic neurons between E5 and E12 (Carr and Simpson, 1978) . At E4.5, DRG are immature with ,30% of the cells being mitotically active progenitor cells (Lefcort, unpublished observations) , and the majority of the remaining cells being nascent, post-mitotic neurons (Pannese, 1974; Rifkin et al., 2000; Wakamatsu et al., 2000) . Gliogenesis becomes prevalent after E6 (Carr and Simpson, 1978) . By E8.5, DRG are considered mature in that neurogenesis is complete, neurons express their mature pattern of neurotransmitters, Trk receptors, and ETS transcription factors, and the majority of fibers have innervated their targets (Pannese, 1974; Carr and Simpson, 1978; Lindsay, 1996; Lin et al., 1998; Arber et al., 2000; Rifkin et al., 2000) . Thus, in order to identify genes that regulate sensory neurogenesis and differentiation we isolated DRG from immature embryos at E4.5, and compared their cDNA to cDNA derived from mature E8.5 DRG. E4.5 and E8.5 DRG were directly compared with a suppressive subtractive hybridization polymerase chain reaction (SSH-PCR)/differential screening methodology (Lukyanov et al., 1995; Munroe et al., 1995; Diatchenko et al., 1996; Von Stein et al., 1997) , the results of which will be published separately (Nelson et al., in preparation) . A candidate cDNA fragment was identified as chicken neural epidermal growth factor-like (NEL, Matsuhashi et al., 1995) , by DNA sequencing and BLAST analysis of GenBank (Altschul et al., 1990) . Two human and rat cDNAs were later independently identified as NEL-Like 1 and NEL-Like 2; chicken NEL is ,40-50% homologous to NELL1, and ,80% homologous to NELL2 (Watanabe et al., 1996; . Therefore, we refer to chicken NEL as NELL2; chicken NELL1 has not yet been identified.
Sequence analysis of NELL2 and initial in vitro biochemical characterization indicate that it is a large peptide, ,90 kDa, with ,50 kDa of N-linked carbohydrate, contains a cleavable N-terminal signal peptide sequence, and in addition to monomers forms putative homotrimers in solution (Matsuhashi et al., 1995; Watanabe et al., 1996; . Furthermore, NELL2 belongs to an intriguing class of proteins that contain EGF-like domains (Engel, 1989; Davis, 1990) , including amongst others, Notch and its ligands Delta/Serrate/Lag (DSL), the Neuregulin (NRG) family of ligands, and the SLIT family of ligands. NELL2 contains six EGF-like domains, which are likely to serve as potential binding sites for novel protein interactions Oyasu et al., 2000) . NELL2 also belongs to the Laminin G/N-terminus Thrombospondin 1 (N-TSP1)/Pentraxin gene superfamily (Beckmann et al., 1998) , a large class of multi-domain adhesive proteins in the extracellular matrix that act as molecular bridges between cells and the matrix, and participate in cell-cell communication. Based on homologies to the Notch/DSL, NRG, SLIT, and TSP1 proteins, NELL2 has been proposed to act as a signaling ligand in similar key developmental events.
Reverse transcriptase-PCR (RT-PCR) confirmation of differential NELL2 expression
To verify that the candidate NELL2 cDNA isolated in our screen was in fact differentially expressed, we used RT-PCR to independently compare the relative expression levels of NELL2 in both immature E4.5 and mature E8.5 DRG (Fig.  1A ). This figure demonstrates that the common, housekeeping transcripts b-actin and glyceraldhyde-3 phosphodehydrogenase (G3PDH) were present at equal amounts in both samples, and the RT(2) controls with G3PDH primers show no genomic DNA contamination in either sample. In confirmation of our subtraction and differential screen, the RT-PCR results demonstrate that NELL2 is more robustly expressed in the immature E4.5 DRG (Fig. 1A(1) ) compared to the mature, differentiated E8.5 DRG ( Fig.  1A(2) ).
1.2. In situ hybridization analysis of NELL2 expression during embryogenesis
NELL2 expression peaks during sensory and motor neuron differentiation
To further analyze NELL2's differential expression during DRG development, we conducted in situ hybridizations on transverse sections of chick embryos at key stages of DRG development (Hamburger and Hamilton, 1951) . NELL2 expression commences with the onset of DRG gangliogenesis (data not shown), and is strongly expressed in DRG by st 21 (Fig. 1H) . Fig. 1B -D demonstrates that at E4.5, NELL2 is specifically expressed in the DRG, including the dorsal pole (arrow), during the peak period of neurogenesis (Fig. 1B) , in agreement with the initial description of NELL2 in the DRG at this stage (Matsuhashi et al., 1995) . Furthermore, within the subsequent 24 h (E5.5, data not shown) NELL2's expression in the DRG significantly decreases, becoming virtually undetectable in maturing E6.5 and mature E8.5 ganglia (Fig. 1C , D, respectively). Interestingly, NELL2 also exhibits a strikingly dynamic pattern of expression in the spinal cord (SC; compare Fig.  1B-D) . NELL2 is initially highly expressed throughout the mantle layer of the SC, a region undergoing differentiation ( Fig. 1B ; see also Matsuhashi, et al., 1995) , with extremely high levels of expression in motor neuron regions (arrowheads). Within the next few days NELL2 expression is rapidly reduced, becoming restricted to discrete motor neuron pools at later stages (Fig. 1C , D, arrowheads), along the rostral-caudal axis in both lateral and medial motor columns. These results prompted us to investigate additional tissues and stages in which NELL2 might be discretely and dynamically expressed. Whole-mount in situ hybridization demonstrates that in addition to expres-sion in the pineal gland (pg), NELL2 is expressed in cranial sensory ganglia and discrete regions within the central nervous system (CNS) (Fig. 1E , arrowheads, discussed later), and in discrete mesodermal derivatives in the limbs and lateral trunk (Fig. 1E , arrows).
NELL2 is expressed by sublineages of the somite and neural crest
To further characterize NELL2's expression, we examined embryos from earlier and later stages of development. Weak NELL2 expression could first be detected in somites and the neural tube at st 13-15 (data not shown). By st 17 (Fig. 1F , G) NELL2 transcripts are upregulated, and can be detected in the lateral edges of somites encompassing the prospective wing bud and trunk levels. Transverse sections at early st 17 (Fig. 1F , small arrowheads) and whole-mounts at st 17 ( Fig. 1G ) indicate that this signal is localized to the lateral edge of the dermomyotome, which contains the skeletal/hypaxial muscle precursor cells that migrate into the limbs and trunk to give rise to all skeletal muscle derivatives (C. Krull, personal communication; Ordhal and Le Douarin, 1992) . NELL2 expression also increases during this period in the neural tube, and by st 17 (Fig. 1F , arrows) strong expression can be detected in the early spinal cord, especially in nascent motor neuron regions, and in a subset of migrating neural crest cells (Fig. 1F, large arrowhead) .
NELL2 is later expressed in discrete regions in the forelimb and lateral trunk mesoderm, by the progeny of the labeled cells detected in the younger somite that have migrated to their target fields. At st 21 NELL2 is expressed In situ hybridization reveals that NELL2 expression is restricted to the peak periods of both motor and sensory neuron differentiation (B, E4.5; C, E6.5; D, E8.5; arrowheads, motor neuron MN). (E) st 21 whole-mount in situ reveals that NELL2 is also discretely expressed in the pineal gland (pg) and other neural tissues (arrowheads, discussed later), and in the forelimb and lateral trunk mesoderm (arrows). (F) Transverse section at early st 17 localizes NELL2 to the lateral edge of dermamyotomes (small arrowheads), in migrating neural crest cells lateral to the dorsal neural tube (large arrowhead), and to a subpopulation of cells in the ventricular layer of the neural tube and nascent motor neuron pools (arrows). (G) st 17 whole-mount demonstrating NELL2 expression in the lateral dermamyotomes (arrowhead). (H,I) At st 21, NELL2 is expressed by hypaxial muscle precursor derivatives in both the dorsal (H) and ventral (I) forelimb (arrow) and lateral body wall (arrowhead), and note the robust expression in the DRG. (J) By st 25 NELL2 is restricted to a discrete region in the dorsal, posterior forelimb (arrow), and lateral trunk mesoderm: note the difference in expression between the forelimb (J) and hindlimb (K). (L,M) Sympathetic ganglia do not express NELL2; (L) alpha-tubulin control, (M) NELL2 (E8.5).
in the posterior region of the dorsal and ventral forelimb (Fig. 1H, I ). Also note the faint labeling in the gut (Fig.  1I, asterisks) , which corresponds to the developing mesonephros and in the heart, corroborating previously reported NELL2 expression in the early kidney and heart (Matsuhashi et al., 1995; Watanabe et al., 1996) . Between st 23 and 25 NELL2 expression in the dorsal forelimb becomes localized to a very discrete posterior region, coinciding with the posterior margin of where the proximal limb extends from the body (Fig. 1J, arrow) . By this stage NELL2 expression in the ventral forelimb is strongly reduced (data not shown). NELL2 expression is maintained in a discrete, proximal region through sections of forelimbs at E6.5 and E8.5 (data not shown). Interestingly, this discrete expression pattern in the forelimb is not observed in the hindlimb, even at later stages (Fig. 1K, arrows) .
Examination at E4.5 clearly indicated a lack of NELL2 expression in the primary chain of sympathetic ganglia, which have just begun to form at ,E4 and develop into the secondary chain by E8 (Lillie, 1908; Lallier and Bronner-Fraser, 1988) . Therefore, we examined sections from E6.5 and E8.5 embryos to determine whether the secondary chain of sympathetic ganglia expressed NELL2; NELL2 expression was not detected in sympathetic ganglia even at this age (Fig. 1L, M ).
1.2.3. NELL2 expression is dynamically regulated during cranial sensory ganglia and pharyngeal arch development NELL2 expression is first weakly detected in the pineal gland anlagen at st 14 (data not shown). By st 17, the pineal gland ( Fig. 2A, arrow) and trigeminal ganglia (T) are clearly labeled. By st 19 NELL2 is upregulated and expressed in all cranial sensory ganglia (Fig. 2B) , and expression peaks during st 21-23 (Fig. 2C, D) . By st 25 (Fig. 2E) NELL2 expression decreases in all cranial sensory ganglia, although it is maintained in the mmV branch of the trigeminal ganglia (Fig. 2D, E) .
Beginning at ,st 19, and by st 21-25 (Fig. 2C , E) NELL2 expression can be detected throughout the pharyngeal arches, during their peak period of development (Lillie, 1908) . By st 25, NELL2 becomes increasingly localized around branchial cleft I, from which the maxilla (anterior) and the mandible (posterior) arise, and continues to be strongly expressed in discrete regions in st 28 embryos (Fig. 2F) . Transient NELL2 expression in the face is detected between st 21 and 25, and decreases between st 26 and 28 (Fig. 2C, E, F) . It is interesting to note that NELL2 expression is maximal in the pharyngeal arch target fields as its expression wanes in the respective innervating neural structures.
NELL2 is expressed by differentiating retinal ganglion cells and in the otic vesicle
One of the first tissues to express NELL2 is the developing eye (,st 14, data not shown). At st 18 (data not shown), NELL2 is clearly expressed in the optic cup, with strong expression through the optic stalk. By st 20 (Fig. 3A , arrows) NELL2 is strongly expressed throughout the retinal region circumscribing the lens. This retinal expression becomes localized to ganglion cells in the inner layer by st 25 (Fig. 3B ; T. Reh, personal communication), which are interspersed with non-NELL2 expressing cells. NELL2 expression in the otic vesicle can be observed in wholemount embryos at st 21-25 (see Fig. 2 ). Transverse sections at st 25 indicate that distinct regions within the vestibularcochlear ganglion (V) express varying levels of NELL2 (Fig.  3C, asterisks) , and that NELL2 is also expressed in discrete regions within the otocyst (Fig. 3C, arrowheads) .
NELL2 expression in the developing CNS
In the CNS, NELL2 is first expressed at ,st 17-18 by a layer of cells in the most lateral region within the neuroepithelium. By st 20 NELL2 is expressed in the wall of the rostral metencephalon (Fig. 5A) , and a population of cells in the ventral floor of the mesencephalon (Fig. 5B) , diencephalon, and telencephalon (data not shown). NELL2 is also intensely expressed in the midbrain floor in more mature embryos at st 25 and 28, (Fig. 4A, B arrows) . NELL2 expression in the floor of the hindbrain is quite dynamic during these periods. By st 21, NELL2 is strongly expressed in the region of the upper and lower rhombic lips (Fig. 4C , top and bottom arrows, respectively), and in two pairs of stripes in the floor of the hindbrain (Fig. 4C ): this ventral expression in the floor extends the entire length of the hindbrain. At st 21, NELL2 expression is diffuse in anterior rhombomeres (R1-2), while discrete stripes are present in more posterior rhombomeres, and expression is also detected between the rhombomeric boundaries (Fig. 4C, arrowheads) . By st 23 (Fig. 4D) , expression in the anterior rhombomeres also becomes restricted to these stripes. At st 25, the medial pair extends the entire length of the hindbrain, through rhombomeres 1-7, while the lateral pair of stripes extend caudally from R2 (Fig. 4Ee , small arrowhead; compare anterior regions in Fig. 4C and Fig. 4Ee ). NELL2 expression in these stripes is significantly reduced after st 25, being barely detectable by st 26 (Fig. 4F , Ff, same embryo rotated forward to view anterior rhombomeres; compare Fig. 4Ee,  Ff) . Furthermore, NELL2 expression in the upper rhombic lip decreases during these stages (compare Fig. 4C top arrow, and Fig. 4Ee, Ff) .
NELL2 is differentially regulated in the CNS and PNS
Except for the very first, weak detection of NELL2 in the spinal cord ventricular zone at the onset of neurogenesis and differentiation, expression of NELL2 in the CNS is restricted exclusively to the differentiating mantle layer of the neuroepithelium, while expression in the PNS (DRG specifically) indicated that NELL2 is located in both differentiating and progenitor zones. To determine directly if mitotically active progenitor cells express NELL2, we combined in situ hybridizations with BrdU labeling (Bermingham-McDonogh et al., 2001) . NELL2 expression throughout the CNS was found not to co-localize with the BrdU1progenitor zones, but rather was detected in adjacent differentiating layers, in particular, the wall of the metencephalon, the floor of the mesencephalon, the retina, and the spinal cord (Fig. 5A, B , D, E, respectively). The only exception to this pattern at these stages in the CNS was observed in the pineal gland, where a subpopulation of BrdU labeled cells also expressed NELL2, although most NELL21cells were BrdU2 (data not shown). This absence of overlap is not the case in the PNS. Sections through both the trigeminal ganglia and DRG at st 20 reveal that indeed mixed populations of Brdu1/ NELL21 (Fig. 5C, arrowhead) and BrdU1/NELL22 coexist. At st 25, during the peak period of neurogenesis in the DRG, while NELL2 is predominately expressed in Brdu2 cells, there still exists a subpopulation of BrdU1/ NELL21cells (Fig. 5F ). Interestingly, in both the PNS and retina, NELL21/BrdU2cells are often observed directly juxtaposed to BrdU1/NELL22cells, in a pattern reminiscent of Notch/Delta expression.
To further confirm that within the DRG NELL2 is expressed by both neurons and progenitor cells, we combined NELL2 in situ hybridization with neurofilament immunocytochemistry (Vargesson et al., 2001) . At st 25 neurofilament antibodies label the neural core of the ganglia and the projections to the spinal cord and target fields (Fig.  5G) . While the majority of NELL2 expressing cells are located in the neural core of the ganglia, NELL2 is also expressed by non-neural cells in both the dorsal pole and in the medial and lateral perimeter of the ganglion adjacent to the spinal cord (arrowheads, fluorescence signal dampens colorimetric signal slighty), both known zones of proliferation within the DRG (Hamburger et al., 1981) .
In summary, these studies demonstrate that NELL2 is spatially and temporally regulated in discrete regions within the nervous system, in particular, the midbrain, hindbrain, retina, spinal cord, and peripheral sensory ganglia. NELL2 expression is maximal during the peak periods of both sensory and motor neuron differentiation (Carr and Simpson, 1978; Leber et al., 1990) . Furthermore, NELL2 marks specific sublineages of the somite and neural crest. NELL2 expression is restricted to hypaxial muscle precursor cells rather than epaxial muscle precursor cells, during the early specification phase of their differentiation program, and continues to be expressed as derivatives migrate to their target fields in the limbs and body wall, being down-regulated as the terminal differentiation program ensues in a manner analogous to Pax3 (compare with Pax3 expression Williams and Ordhal, 1994; Brand-Saberi and Christ, 1999; Stockdale et al., 2000) . Thus, NELL2 is a new marker for this early phase of hypaxial muscle differentiation. Furthermore, NELL2 specifically marks the sensory neural lineage of the neural crest rather than the sympathetic or melanocyte lineage at any stage examined. This restricted expression pattern is similar to that of the neurogenins 1 and 2, which are necessary for DRG formation, regulate distinct waves of neurogenesis within the DRG, and bias neural crest to a sensory neural fate (Sommer et al., 1996; Perez et al., 1999; Ma et al., 1999) . Finally NELL2 is differentially regulated between the CNS and PNS in that it is excluded from neural progenitor zones within the CNS, while a subset of mitotically active progenitor cells in the PNS express NELL2. Studies directed toward elucidating the functional significance of this differential expression and NELL2's role during muscle and neuronal development are currently in progress.
Methods

Identification of NELL2 during sensory neurogenesis and differentiation
Fertilized white leghorn eggs were obtained (Spafas), and grown to appropriate stages (Hamburger and Hamilton, 1951) . All embryos were treated in accordance with IACUC stipulations. SSH-PCR was used to identify differentially expressed genes between immature, embryonic day 4.5 DRG (E4.5 DRG) and mature, differentiated E8.5 DRG (Lukyanov et al., 1995; Diatchenko et al., 1996) . The E4.5 DRG cDNA subtraction library was screened for candidate differentially expressed clones (Munroe et al., 1995; Von Stein et al., 1997) , the details of which will be published separately (Nelson et al, in preparation).
RT-PCR confirmation of differential NELL2 expression
E4.5 DRG and E8.5 DRG were collected and total RNA isolated with standard techniques, quantified by measuring absorption at 260/280 nm, and concentration normalized for RT-PCR analysis. MacVector 6.5.3 (Oxford Molecular) was used to design specific primers from available sequence data for chicken NELL2, and the normalization controls G3PDH and b-actin: NELL2 (forward 5 The ACCESS System (Promega) was used for single-step RT-PCR from total RNA, as directed. Equal concentrations of E4.5 and E8.5 DRG total RNA were used to analyze the relative expression levels of NELL2 at these developmental stages (150 ng for controls, 250 ng for NELL2). 5 ul aliquots were removed at 20 £ , 30 £ , and 40 £ cycles of PCR and analyzed on 2% Ag/EtBr gels. Single bands corresponding to the correct sizes were detected for NELL2 and controls. RT(2) control was performed with the G3PDH primer set. Results for 30 £ cycles shown.
In situ hybridizations
A series of chick embryos at selected stages were collected. Whole-mount in situ hybridization and section in situ hybridization were performed with DIG-labeled ribo-probes as described with slight modifications (Henrique et al., 1995; Chen et al., 1998; Etchevers et al., 2001 ). DIG-labeled NELL2 probes were generated from the same template as in Matsuhashi et al., 1995 , which gave the same results. Sense-control probes gave no signal and are not shown. Detection of differential signal in E4.5, E6.5, and E8.5 DRG and SC was performed by allowing the slides to react at the same time with prepared nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate p-toluidine (NBT/BCIP) color substrate (Sigma) until optimal signal-to-noise was reached, which always occurred first with the E4.5 slides, all of which were then post-fixed with 4% paraformaldehyde, and coverslipped. Alpha-tubulin DIG-labeled control probe has been described (Miller at al., 1987; Gloster et al., 1994) .
Combined in situ hybridizations, BrdU, and neurofilament labeling
BrdU was injected in ovo into st 20 and st 25 embryos, eggs were sealed with plastic tape and incubated for 4 h, processed for in situ hybridizations (Etchevers et al., 2001 , without proteinase K treatment) and BrdU incorporation (Bermingham-McDonogh et al., 2001) , or neurofilament detection (Vargesson et al., 2001) .
